Is major liver surgery associated with an increased systemic inflammatory response? A prospective comparison of hemihepatectomy and other major abdominal surgery

Liver

Volumn 19, Issue 3, 1999, Pages 220-227

  Wiezer, Marinus J ^a   Meijer, Catharina ^a   Vuylsteke, Ronald ^a   Pullens, Renee H ^a   Prins, Hubert A ^a   Cuesta, Miguel A ^a   Meijer, Sybren ^a   Hack, C Erik ^a   Van Leeuwen, Paul A M ^a,b  

^a CENTRAL LABORATORY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clearance; Cytokines; Hemihepatectomy; Human; Inflammatory response; Liver resection; Prospective

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYTOKINE; ELASTASE; INTERLEUKIN 6; INTERLEUKIN 8; LACTOFERRIN; PHOSPHOLIPASE A2;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMIHEPATECTOMY; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; LIVER CLEARANCE; LIVER FAILURE; LIVER FUNCTION; LIVER RESECTION; LIVER TUMOR; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE COMPLICATION;

EID: 0032979049     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00039.x     Document Type: Article

References (38)

1. FORTNER J G, SILVA J S, GOLBY R B, et al. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 1984; 199: 306-16.
2. THOMPSON H H, TOMPKINS R K, LONGMIRE WP. Major hepatic resection. A 25-year experience. Ann Surg 1983; 197: 375-88.
3. IWATSUKI S, STARZL TE. Personal experience with 411 hepatic resections. Ann Surg 1988; 208: 421-34.
4. BELGHITI J, DI CARLO I, SAUVANET A, et al. A ten-year experience with hepatic resection in 338 patients: evolutions in indications and of operative mortality. Eur J Surg 1994; 160: 277-82.
5. STIMPSON R E J, PELLEGRINI C A, WAY L W. Factors affecting the morbidity of elective liver resection. Am J Surg 1990; 77: 1247-50.
6. SAVAGE A P, MALT R A. Elective and emergency hepatic resection. Determinants of operative mortality and morbidity. Ann Surg 1991; 214: 689-95.
7. YANAGA K, KANEMATSA T, TAKENAKA K, SUGIMACHI K. Intra-peritoneal septic complications after hepatectomy. Ann Surg 1986; 203: 148-52.
8. GONELLA P A, HELTON W S, ROBINSON M, et al. O-side chain of Escherichia coli endotoxin 0111:B4 is translocated across the intestinal epithelium in the rat: evidence for increased transport during total parenteral nutrition. Eur J Cell Biol 1992; 59: 224-7.
9. SONNE O, DAVIDSON O, MOLLER B K, MUNCK PETERSEN C. Cellular targets and receptors for interleukin-6. I. In vivo and in vitro uptake of IL-6 in liver and hepatocytes. Eur J Clin Invest 1990; 20: 366-76.
10. IMBER M J, PIZZO S V. Clearance and binding of native and defucosylated lactoferrin. Biochem J 1983; 212: 249-57.
11. PERLMUTTER D H, JOSLIN G, NELSON P, et al. Endocytosis and degradation of alpha 1-antitrypsin-protease complexes is mediated by the serpin-enzyme complex (SEC) receptor. J Biol Chem 1990; 265: 16713-6.
12. CASTELL J V, GEIGER T, GROSS V, et al. Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte stimulating factor in the rat. Eur J Biochem 1988; 177: 357-61.
13. KRISTIANSSON M, SOOP M, SERASTE E, SUNDQVIST KG. Post-operative circulating cytokine patterns - the influence of infection. Intensive Care Med 1993; 19: 395-400.
14. FASSBENDER K, PARGGER H, MULLER W, ZIMMERLI W. Interleukin-6 and acute-phase protein concentrations in surgical intensive care unit patients: diagnostic signs in nosocomial infection. Crit Care Med 1993; 21: 1175-80.
15. MUELLER A R, PLATZ K P, WIEHE I, et al. Cytokine pattern in patients with infections after liver transplantation. Transpl Int 1996; 9: S126-31.
16. SAUTNER T, FUGGER R, GOTZINGER P, et al. Tumour necrosis factor-alpha and interleukin-6: early indicators of bacterial infection after human orthotopic liver transplantation. Eur J Surg 1995; 161: 97-101.
17. BADIA J M, AYTON L C, EVANS T J, et al. Systemic cytokine response to hepatic resections under total vascular exclusion. Eur J Surg 1998; 164: 185-90.
18. HELLE M, BOEIJE E, DE GROOT E R, et al. Sensitive ELISA for interleukin-6: detection of IL-6 in biological fluid, synovial fluids and sera. J Immunol Methods 1991; 38: 47-56.
19. BRAKENHOFF J P J, DE GROOT E, EVERS R F, et al. Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol 1987; 39: 4116-21.
20. HACK C E, HART M, STRACK VAN SCHIJNDEL R J M, et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992; 60: 2835-42.
21. SMITH G M, WARD R L, MCGUIGAN L, et al. Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol 1992; 31: 175-8.
22. 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med 1992; 119: 159-68.
23. MAN K, FAN S T, NG I O L, LO C M, LIU C L, WONG J. Prospective evaluation of pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 1997; 226: 704-13.
24. VADAS P, PRUZANSKI W, FAREWELL V. A predictive model for the clearance of soluble phospholipase A2 during septic shock. J Lab Clin Med 1991; 118: 471-5.
25. GARRISON R N, CRYER H M, HOWARD D A, POLK H C. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984; 199: 648-55.
26. JAMIESON G G, CORBEL L, CAMPION J P, LANOIS B. Major liver resection without a blood transfusion: Is it a realistic objective? Surgery 1992; 112: 32-6.
27. FUJISHIMA S, AIKAWA N. Neutrophil-mediated tissue injury and its modulation. Intensive Care Med 1995; 21: 277-85.
28. ELLSTROM M, BENGTSSON A, TYLMAN M, et al. Evaluation of tissue trauma after laparoscopic and abdominal hysterectomy: measurements of neutrophil activation and release of interleukin-6, cortisol, and C-reactive protein. J Am Coll Surg 1996; 182:423-30.
29. ANDERSON B O. BROWN J M, HARKEN A H. Mechanisms of neutrophil-mediated tissue injury. J Surg Research 1991; 51: 170-9.
30. BOERMEESTER M A, HOUDIJK A P J, MEYER S, et al. Liver failure induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal/permeability increasing protein. Am J Pathol 1995; 147: 1428-40.
31. VAN LEEUWEN P A M, HONG R W, ROUNDS J D, et al. Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin. Surgery 1991; 110: 169-75.
32. VAN DEVENTER S J, BULLER H R, TEN CATE J W, et al. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76: 2520-6.
33. O'GRADY J G, SCHALM S W, WILLIAMS R. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273-5.
34. DEACIUC I V, ALAPPAT J M, MCDONOUGH K H, D'SOUZA N B. Effect of chronic alcohol consumption by rats on tumor necrosis factor-alpha and interleukin-6 clearance in vivo and by the isolated, perfused liver. Biochem Pharmacol 1996; 52: 891-9.
35. MAGLECH H L, GALLIN J I. Current concepts: Neutrophils in human diseases. N Engl J Med 1987; 317: 687-94.
36. WANSCHER M, ANTONSON S, TOFT P, et al. Attenuation of intraoperative surgical stress response has no influence on post-operative degranulation of polymorphonuclear granulocytes. Eur J Anaesthesiol 1991; 8: 393-400.
37. DUSWALD KH, JOCHUM M, SCHRAMM W, FRITZ H. Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. Surgery 1985; 98: 892-9.
38. YAMANAKA N, OKAMOTO E, ORIYAMA T, et al. A prediction scoring system to select the surgical treatment of liver cancer. Ann Surg 1994; 219: 342-6.